PLVAP Antikörper
(1 reference)-
- Target Alle PLVAP Antikörper anzeigen
- PLVAP (Plasmalemma Vesicle Associated Protein (PLVAP))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PLVAP Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Aufreinigung
- Immunogen affinity purified
- Reinheit
- ≥95 % as determined by SDS-PAGE
- Immunogen
- plasmalemma vesicle associated protein
- Isotyp
- IgG
- Top Product
- Discover our top product PLVAP Primärantikörper
-
anti-Plasmalemma Vesicle Associated Protein (PLVAP) (AA 123-393) antibody
PLVAP Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Plasmalemma Vesicle Associated Protein (PLVAP) (AA 214-242) antibodyPLVAP Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB17891 unconjugated
anti-Plasmalemma Vesicle Associated Protein (PLVAP) (AA 51-150) antibodyPLVAP Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Plasmalemma Vesicle Associated Protein (PLVAP) (AA 63-442) antibodyPLVAP Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Plasmalemma Vesicle Associated Protein (PLVAP) (AA 203-442) antibodyPLVAP Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Plasmalemma Vesicle Associated Protein (PLVAP) (AA 221-250), (Middle Region) antibodyPLVAP Reaktivität: Human WB, FACS, EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB : 1:500-1:1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Haltbarkeit
- 12 months
-
-
: "Effect of acid sphingomyelinase deficiency in type A Niemann-Pick disease on the transport of therapeutic nanocarriers across the blood-brain barrier." in: Drug delivery and translational research, (2023) (PubMed).
-
: "Effect of acid sphingomyelinase deficiency in type A Niemann-Pick disease on the transport of therapeutic nanocarriers across the blood-brain barrier." in: Drug delivery and translational research, (2023) (PubMed).
-
- Target
- PLVAP (Plasmalemma Vesicle Associated Protein (PLVAP))
- Andere Bezeichnung
- PLVAP (PLVAP Produkte)
- Synonyme
- MECA32 antikoerper, Pv1 antikoerper, FELS antikoerper, PV-1 antikoerper, PV1 antikoerper, gp68 antikoerper, plasmalemma vesicle associated protein antikoerper, Plvap antikoerper, PLVAP antikoerper
- Hintergrund
- Synonyms:FELS, gp68, Plasmalemma vesicle protein 1, PLVAP, PV 1, PV1 Background:Involved in the formation of stomatal and fenestral diaphragms of caveolae. May function in microvascular permeability.
- Molekulargewicht
- 51 kDa
- Gen-ID
- 83483
- UniProt
- Q9BX97
-
